Skip to main content
. 2016 May 12;16:85. doi: 10.1186/s12866-016-0699-2

Table 2.

Comparison of drug susceptibility patterns between clinical M. tuberculosis isolates in 2006 and in 2012

Susceptibility or resistance category Total cases New cases Previously treated cases
2006 (n = 255)
n (%)
2012 (n = 537)
n (%)
P value 2006 (n = 176)
n (%)
2012 (n = 318)
n (%)
P value 2006 (n = 79)
n (%)
2012 (n = 219)
n (%)
P value
Any drug-resistance 89 (34.9) 292 (54.4) <0.001 37 (21.0) 115 (36.2) 0.001 52 (65.8) 177 (80.8) 0.007
All first-line drug resistance 78 (30.6) 269 (50.1) <0.001 30 (17.0) 98 (30.8) 0.001 48 (60.8) 171 (78.1) 0.003
INH 60 (23.5) 209 (38.9) <0.001 20 (11.4) 57 (17.9) 0.054 40 (50.6) 152 (69.4) 0.003
RIF 43 (16.9) 164 (30.5) <0.001 5 (2.8) 30 (9.4) 0.006 38 (48.1) 134 (61.2) 0.044
STR 59 (23.1) 189 (35.2) 0.001 21 (11.9) 63 (19.8) 0.026 38 (48.1) 126 (57.5) 0.149
EMB 24 (9.4) 88 (16.4) 0.008 8 (4.5) 31 (9.7) 0.040 16 (20.3) 57 (26.0) 0.306
All MDR 38 (14.9) 145 (27.0) <0.001 5 (2.8) 21 (6.6) 0.073 33 (41.8) 124 (56.6) 0.023
INH + RIF 4 (2.0) 25 (4.5) 0.079 1 (0.6) 4 (1.3) 0.463 3 (3.8) 21 (9.6) 0.105
INH + RIF + STR/EMB 34 (13.3) 120 (22.3) 0.003 4 (2.3) 17 (5.3) 0.105 30 (38.0) 103 (47.0) 0.165
All second-line drug resistance 40 (15.7) 172 (32.0) <0.001 14 (8.0) 45 (14.2) 0.042 26 (32.9) 127 (58.0) <0.001
OFX 37 (14.5) 164 (30.5) <0.001 13 (7.4) 42 (13.2) 0.049 24 (30.4) 122 (55.7) <0.001
CAP 1 (0.4) 29 (5.4) 0.001 1 (0.6) 2 (0.6) 0.934 0 27 (12.3) 0.001
AMK 9 (3.5) 42 (7.8) 0.021 1 (0.6) 7 (2.2) 0.168 8 (10.1) 35 (16.0) 0.204
All pre-XDR 17 (6.7) 73 (13.6) 0.004 2 (1.1) 10 (3.1) 0.165 15 (19.0) 63 (28.8) 0.090
All XDR 6 (2.4) 36 (6.9) 0.008 1 (0.6) 4 (1.3) 0.463 5 (6.3) 32 (14.6) 0.056